Vilazodone Hydrochloride NDC 62332-233

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-233Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0233Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62332-233-30	62332023330	30 TABLET, FILM COATED in 1 BOTTLE (62332-233-30)Marketed from Jun 4, 2022
62332-233-71	62332023371	500 TABLET, FILM COATED in 1 BOTTLE (62332-233-71)Marketed from Jun 4, 2022
62332-233-90	62332023390	90 TABLET, FILM COATED in 1 BOTTLE (62332-233-90)Marketed from Jun 4, 2022
62332-233-91	62332023391	1000 TABLET, FILM COATED in 1 BOTTLE (62332-233-91)Marketed from Jun 4, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Vilazodone Hydrochloride
Generic name (nonproprietary): vilazodone hydrochloride
Active ingredients: Vilazodone hydrochloride — 20 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Alembic Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208202
Marketing start: Jun 4, 2022
Listing expires: Dec 31, 2026
Identifiers: Product ID 62332-233_d97cafa3-ede7-49c6-bba1-6414e6968cb5SPL ID d97cafa3-ede7-49c6-bba1-6414e6968cb5SPL set ID 8b95b850-8bdf-4255-a691-783d1a94bd07RxCUI 1086772, 1086778, 1086784UNII U8HTX2GK8JUPC 0362332232307, 0362332234301

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332023330 followed by a unit qualifier and the quantity

Package 62332-0233-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 26, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Vilazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults [see Clinical Studies (14)]. Vilazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 208202

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208202
Product	Strength	Form · route	Labeler	Product NDC
Vilazodone Hydrochloride	Vilazodone hydrochloride 20 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-233
Vilazodone Hydrochloride	Vilazodone hydrochloride 10 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-232
Vilazodone Hydrochloride	Vilazodone hydrochloride 40 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-234
Vilazodone Hydrochloride	Vilazodone hydrochloride 40 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-234
Vilazodone Hydrochloride	Vilazodone hydrochloride 10 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Inc.	62332-232